Arkema (OTCMKTS:ARKAY) Announces Earnings Results
by Sarita Garza · The Markets DailyArkema (OTCMKTS:ARKAY – Get Free Report) issued its quarterly earnings results on Thursday. The basic materials company reported $1.40 earnings per share for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.09), Zacks reports. Arkema had a net margin of 0.67% and a return on equity of 4.30%.
Arkema Price Performance
Shares of OTCMKTS ARKAY traded up $1.36 during trading on Thursday, hitting $66.06. The company had a trading volume of 887 shares, compared to its average volume of 1,887. Arkema has a 52 week low of $56.28 and a 52 week high of $79.36. The business’s 50-day moving average is $64.29 and its 200 day moving average is $66.92. The company has a market cap of $5.02 billion, a P/E ratio of 13.82 and a beta of 0.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.08 and a current ratio of 1.52.
Analyst Ratings Changes
Separately, Barclays raised shares of Arkema from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 12th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce”.
Get Our Latest Stock Report on ARKAY
Arkema Company Profile
Arkema is a France-based global specialty materials company that develops and manufactures products used in a wide range of industrial and consumer applications. Its portfolio includes specialty adhesives, high-performance polymers, acrylic materials, coating resins, additives and other chemical solutions designed to improve durability, performance and sustainability.
The company operates through businesses focused on Adhesive Solutions, Advanced Materials and Coating Solutions. Its products serve markets such as construction, automotive, electronics, packaging, renewable energy, consumer goods and industrial manufacturing.
Read More
- Five stocks we like better than Arkema
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market